Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

P3 Health Partners Inc (PIII)

P3 Health Partners Inc (PIII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

New Partnership Strengthens Value-Based Care Platform for Primary Care Providers

PIII : 3.39 (-6.93%)
P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference

Henderson, Nevada--(Newsfile Corp. - November 24, 2025) - P3 Health Partners Inc. (NASDAQ: PIII) ("P3"), a patient-centered and physician-led population health management company, today announced that...

PIII : 3.39 (-6.93%)
P3 Health Partners Announces Third Quarter 2025 Results

P3 Reports Continued Operational Progress and Expansion of Care Enablement Model in a Transitional Year $120 to $170 Million EBITDA Expansion Opportunity Strengthens Path...

PIII : 3.39 (-6.93%)
P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its...

PIII : 3.39 (-6.93%)
P3 Health Partners to Participate in the Jefferies Healthcare Services Conference

P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Jefferies Healthcare...

PIII : 3.39 (-6.93%)
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025

iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025

SKYH : 9.15 (+1.78%)
XTRA.TO : 0.4550 (-3.19%)
CJMB : 1.7750 (+0.85%)
XTRAF : 0.3400 (+0.59%)
PMNT : 0.2268 (-2.24%)
TOMZ : 0.6700 (+3.44%)
SKYX : 1.9500 (-0.26%)
HIT : 1.8500 (-2.63%)
NNBR : 1.2900 (-0.77%)
AENT : 6.80 (-1.02%)
ACNT : 12.81 (-1.46%)
PRSO : 1.3800 (-9.21%)
iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025

RALEIGH, NC / ACCESS Newswire / September 9, 2025 / iAccess Alpha's Virtual Best Ideas Fall Investment Conference will take place on September 16-17, 2025, bringing together top micro-cap companies and...

XTRA.TO : 0.4550 (-3.19%)
CJMB : 1.7750 (+0.85%)
XTRAF : 0.3400 (+0.59%)
TOMZ : 0.6700 (+3.44%)
SKYX : 1.9500 (-0.26%)
HIT : 1.8500 (-2.63%)
NNBR : 1.2900 (-0.77%)
AENT : 6.80 (-1.02%)
ACNT : 12.81 (-1.46%)
PRSO : 1.3800 (-9.21%)
PIII : 3.39 (-6.93%)
RNXT : 0.8010 (-2.32%)
Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States

GREENWOOD VILLAGE, Colo. , Aug. 25, 2025 /PRNewswire/ -- Catalyst Solutions is thrilled to announce the successful go-live of the Professional Health Partners Services (P3) Implementation,...

PIII : 3.39 (-6.93%)
P3 Health Partners Announces Second Quarter 2025 Results

Core Business Demonstrates Strength with Flat Medical Cost Trends Despite Industry Inflation $120-$170 Million in Additional EBITDA Opportunities...

PIII : 3.39 (-6.93%)
P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call

P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for...

PIII : 3.39 (-6.93%)

Barchart Exclusives

Should You Buy Vertiv Stock Before March 23?
Vertiv stock surged to an all-time high on news of its inclusion in the S&P 500. Here's what investors need to know. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar